Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BIIB Biogen	$135.21 +4.9%	$129.93	$110.04 ▼ $207.59	$18.90B	0.13	1.51 million shs	1.55 million shs
LUV Southwest Airlines	$30.97 +0.8%	$33.00	$23.82 ▼ $37.96	$16.13B	1.26	12.59 million shs	7.88 million shs
NLOK NortonLifeLock	$31.85 +3.5%	$29.74	$20.12 ▼ $30.92	$18.20B	0.76	5.78 million shs	5.03 million shs

The Best High-Yield Dividend Stocks for 2025

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BIIB Biogen	+4.87%	+4.53%	+1.57%	+9.30%	-33.74%
LUV Southwest Airlines	+0.72%	+4.29%	-17.91%	-2.70%	+21.83%
NLOK NortonLifeLock	+3.51%	+11.44%	+11.01%	+11.36%	+29.37%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BIIB Biogen	4.9562 of 5 stars	4.2	4.0	0.0	3.7	3.8	2.5	2.5
LUV Southwest Airlines	4.3975 of 5 stars	1.9	4.0	1.7	0.4	2.8	3.3	3.1
NLOK NortonLifeLock	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BIIB Biogen	2.34	Hold	$185.63	37.29% Upside
LUV Southwest Airlines	1.89	Reduce	$33.06	6.76% Upside
NLOK NortonLifeLock	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest NLOK, BIIB, and LUV Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/5/2025	LUV Southwest Airlines	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$25.00 ➝ $30.00
8/1/2025	BIIB Biogen	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$125.00 ➝ $135.00
8/1/2025	BIIB Biogen	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$208.00 ➝ $219.00
8/1/2025	BIIB Biogen	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$146.00 ➝ $144.00
8/1/2025	BIIB Biogen	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$187.00 ➝ $194.00
7/25/2025	LUV Southwest Airlines	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	In-Line ➝ In-Line	$40.00 ➝ $34.00
7/24/2025	LUV Southwest Airlines	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Moderate Sell
7/24/2025	LUV Southwest Airlines	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Hold ➝ Reduce
7/21/2025	BIIB Biogen	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Hold	$142.00
7/15/2025	LUV Southwest Airlines	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ In-Line	$40.00
7/10/2025	LUV Southwest Airlines	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$26.00 ➝ $34.00

(Data available from 8/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BIIB Biogen	$9.68B	2.05	$24.23 per share	5.58	$120.28 per share	1.12
LUV Southwest Airlines	$27.48B	0.59	$3.79 per share	8.17	$15.23 per share	2.03
NLOK NortonLifeLock	$2.82B	6.46	N/A	N/A	N/A	∞

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BIIB Biogen	$1.63B	$10.46	12.93	8.19	1.01	15.31%	13.85%	8.32%	10/29/2025 (Estimated)
LUV Southwest Airlines	$465M	$0.66	46.92	13.12	0.80	1.43%	6.27%	1.83%	10/23/2025 (Estimated)
NLOK NortonLifeLock	N/A	$1.43	22.27	∞	N/A	N/A	N/A	N/A	N/A

Latest NLOK, BIIB, and LUV Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
7/31/2025	Q2 2025	BIIB Biogen	$3.93	$5.47	+$1.54	$4.33	$2.32 billion	$2.65 billion
7/23/2025	Q2 2025	LUV Southwest Airlines	$0.51	$0.43	-$0.08	$0.39	$7.30 billion	$7.24 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BIIB Biogen	N/A	N/A	N/A	N/A	N/A
LUV Southwest Airlines	$0.72	2.32%	N/A	109.09%	N/A
NLOK NortonLifeLock	$0.50	1.57%	N/A	34.97%	N/A

Latest NLOK, BIIB, and LUV Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/31/2025	LUV Southwest Airlines	quarterly	$0.18	2.36%	9/3/2025	9/3/2025	9/24/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BIIB Biogen	0.36	2.50	1.79
LUV Southwest Airlines	0.51	0.56	0.49
NLOK NortonLifeLock	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BIIB Biogen	87.93%
LUV Southwest Airlines	80.82%
NLOK NortonLifeLock	94.86%

Insider Ownership

Company	Insider Ownership
BIIB Biogen	0.18%
LUV Southwest Airlines	0.79%
NLOK NortonLifeLock	3.30%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BIIB Biogen	7,605	146.62 million	146.35 million	Optionable
LUV Southwest Airlines	72,450	525.19 million	521.04 million	Optionable
NLOK NortonLifeLock	N/A	571.37 million	N/A	No Data

NLOK, BIIB, and LUV Headlines

Recent News About These Companies

NortonLifeLock (NASDAQ:NLOK) Stock Price Up 0.4% - Time to Buy?

July 23, 2025 | marketbeat.com

Gen Digital Inc. (NLOK.VI)

August 30, 2024 | finance.yahoo.com

Gen Digital Inc 1NLOK

July 25, 2024 | morningstar.comM

Gen Digital (GEN) Earnings Dates & Reports

August 4, 2023 | investing.com

Time to question our dividend-based stock screen

August 1, 2023 | investorschronicle.co.uk

Gen Digital (NASDAQ: GEN)

July 8, 2023 | fool.com

Gen Digital (GEN) Beats on Q4 Earnings and Revenue Estimates

May 12, 2023 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

NLOK, BIIB, and LUV Company Descriptions

Biogen NASDAQ:BIIB

$135.21 +6.28 (+4.87%)

Closing price 08/13/2025 03:59 PM Eastern

Extended Trading

$134.92 -0.29 (-0.21%)

As of 07:39 AM Eastern

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; ADUHELM to treat Alzheimer's disease; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar referencing REMICADE; and BYOOVIZ, a ranibizumab biosimilar referencing LUCENTIS. It offers RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; OCREVUS for relapsing MS and primary progressive MS; LUNSUMIO to treat relapsed or refractory follicular lymphoma; glofitamab for non-Hodgkin's lymphoma; and other anti-CD20 therapies. In addition, the company is developing various products for the treatment of MS, Alzheimer's disease and dementia, neuromuscular disorders, Parkinson's disease and movement disorders, neuropsychiatry, genetic neurodevelopmental disorders, and biosimilars, which are under various stages of development. It has collaboration and license agreements with Acorda Therapeutics, Inc.; Alkermes Pharma Ireland Limited; Denali Therapeutics Inc.; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis Pharmaceuticals, Inc.; Samsung Bioepis Co., Ltd.; Sangamo Therapeutics, Inc.; and Sage Therapeutics, Inc., as well as collaboration with Fujirebio to potentially identify and develop blood-based biomarkers for tau pathology in the brain. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.

Southwest Airlines NYSE:LUV

$30.97 +0.25 (+0.81%)

Closing price 08/13/2025 03:59 PM Eastern

Extended Trading

$30.95 -0.02 (-0.06%)

As of 07:37 AM Eastern

Southwest Airlines Co. operates as a passenger airline company that provides scheduled air transportation services in the United States and near-international markets. As of December 31, 2023, the company operated a total fleet of 817 Boeing 737 aircraft; and served 121 destinations in 42 states, the District of Columbia, and the Commonwealth of Puerto Rico, as well as ten near-international countries, including Mexico, Jamaica, the Bahamas, Aruba, the Dominican Republic, Costa Rica, Belize, Cuba, the Cayman Islands, and Turks and Caicos. It also provides inflight entertainment and connectivity services on Wi-Fi enabled aircraft; and Rapid Rewards loyalty program that enables program members to earn points for dollars spent on Southwest base fares. In addition, the company offers a suite of digital platforms to support customers' travel needs, including websites and apps; and SWABIZ, an online booking tool. Further, it provides ancillary services, such as Southwest's EarlyBird Check-In, upgraded boarding, and transportation of pets and unaccompanied minors. Southwest Airlines Co. was incorporated in 1967 and is headquartered in Dallas, Texas.

NortonLifeLock NASDAQ:NLOK

$31.85 +1.08 (+3.51%)

As of 08/12/2025

Gen Digital, Inc. engages in the provision of security, storage, and systems management solutions. The firm focuses on providing consumer cyber safety with its business solutions. The company was founded by Gary Hendrix in April 1982 and is headquartered in Tempe, AZ.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time